Why the study?
Does the MMP-3 5A/6A promoter polymorphism contribute to age-related large artery stiffening in low cardiovascular risk individuals?
Population
203 low cardiovascular risk, unmedicated individuals, divided prospectively into two age groups. Additional…
Comparison
MMP-3 5A/6A promoter polymorphism homozygote… vs MMP-3 5A/6A promoter polymorphism heterozygote…
Design
Cross-sectional
Authors
Loading...
May link MMP-3 5A/6A homozygosity to higher aortic impedance in older low-risk adults; hypothesis-generating and requires longitudinal confirmation.
Does the MMP-3 5A/6A promoter polymorphism contribute to age-related large artery stiffening in low cardiovascular risk individuals?
The MMP-3 5A/6A genotype is associated with age-related large artery stiffening, suggesting heterozygotes maintain an optimal balance of vascular matrix remodeling.
Medley et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: